Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

The Role of Patents and Licensing in the Governance of Human Genome Editing: A White Paper

Matthews, Duncan ; Brown, Abbe ; Gambini, Emanuela ; McMahon, Aisling ; Minssen, Timo LU ; Nordberg, Ana LU orcid ; Sherkow, Jacob S. ; Wested, Jakob and Van Zimmeren, Esther (2021)
Abstract
On 12 July 2021 the World Health Organization (WHO) Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing published a set of reports entitled Human Genome Editing: A Framework for Governance and Recommendations. These reports provide valuable advice and recommendations on appropriate institutional, national and global governance mechanisms for human genome editing. The Expert Advisory Committee’s A Framework for Governance highlights explicitly the role that patents and licences can play as a form of governance of human genome editing. The Recommendations state that the Committee ‘believes that governance measures based on patents or [other forms of] intellectual property, when used... (More)
On 12 July 2021 the World Health Organization (WHO) Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing published a set of reports entitled Human Genome Editing: A Framework for Governance and Recommendations. These reports provide valuable advice and recommendations on appropriate institutional, national and global governance mechanisms for human genome editing. The Expert Advisory Committee’s A Framework for Governance highlights explicitly the role that patents and licences can play as a form of governance of human genome editing. The Recommendations state that the Committee ‘believes that governance measures based on patents or [other forms of] intellectual property, when used together with other tools, may help strengthen the governance and oversight of human genome editing’ [and that] ‘It will be important to avoid using patents in ways that potentially prevent others from delivering similar capabilities at a cheaper cost’. This paper responds to the recommendations of the Expert Advisory Committee and elaborates further on the role that patents and licensing can play in the governance of human genome editing. It concludes with our own recommendations on how the role of patents and licensing can be considered further in the light of the WHO Expert Advisory Committee’s reports. (Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; and
organization
publishing date
type
Book/Report
publication status
published
subject
keywords
Genome editing governance, Patent law, Patent licenses, Genome editing patents, CRISPR-Cas systems/genetics, Emerging health technology, WHO, Medical law, Private law, Patenträtt, Medicinsk rätt, Civilrätt
edition
2021
pages
52 pages
publisher
Queen Mary, University of London, School of Law Legal Studies Research Paper Series
report number
364
language
English
LU publication?
yes
id
b8a16a1f-9313-47fb-8a8e-45d3e0ddff39
date added to LUP
2021-08-02 09:07:10
date last changed
2022-10-10 13:44:51
@techreport{b8a16a1f-9313-47fb-8a8e-45d3e0ddff39,
  abstract     = {{On 12 July 2021 the World Health Organization (WHO) Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing published a set of reports entitled Human Genome Editing: A Framework for Governance and Recommendations. These reports provide valuable advice and recommendations on appropriate institutional, national and global governance mechanisms for human genome editing. The Expert Advisory Committee’s A Framework for Governance highlights explicitly the role that patents and licences can play as a form of governance of human genome editing. The Recommendations state that the Committee ‘believes that governance measures based on patents or [other forms of] intellectual property, when used together with other tools, may help strengthen the governance and oversight of human genome editing’ [and that] ‘It will be important to avoid using patents in ways that potentially prevent others from delivering similar capabilities at a cheaper cost’. This paper responds to the recommendations of the Expert Advisory Committee and elaborates further on the role that patents and licensing can play in the governance of human genome editing. It concludes with our own recommendations on how the role of patents and licensing can be considered further in the light of the WHO Expert Advisory Committee’s reports.}},
  author       = {{Matthews, Duncan and Brown, Abbe and Gambini, Emanuela and McMahon, Aisling and Minssen, Timo and Nordberg, Ana and Sherkow, Jacob S. and Wested, Jakob and Van Zimmeren, Esther}},
  institution  = {{Queen Mary, University of London, School of Law Legal Studies Research Paper Series}},
  keywords     = {{Genome editing governance; Patent law; Patent licenses; Genome editing patents; CRISPR-Cas systems/genetics; Emerging health technology; WHO; Medical law; Private law; Patenträtt; Medicinsk rätt; Civilrätt}},
  language     = {{eng}},
  month        = {{07}},
  number       = {{364}},
  title        = {{The Role of Patents and Licensing in the Governance of Human Genome Editing: A White Paper}},
  url          = {{https://lup.lub.lu.se/search/files/100796208/The_Role_of_Patents_and_Licensing_in_the_Governance_of_Human_Genome_Editing_A_White_Paper1.pdf}},
  year         = {{2021}},
}